Oramed Pharmaceuticals (ORMP) Notes Payables (2020 - 2025)
Oramed Pharmaceuticals (ORMP) reported Notes Payables of $652000.0 for Q4 2025, up 98.18% on a YoY basis from $329000.0 in Q4 2024, and up 65100.0% quarter-over-quarter from $1000.0 in Q3 2025.
Oramed Pharmaceuticals (ORMP) Notes Payables (2020 - 2025) Analysis & Trends
Oramed Pharmaceuticals has reported Notes Payables for 6 years, with the latest figure at $652000.0 in Q4 2025.
- For the quarter ending Q4 2025, Notes Payables rose 98.18% year-over-year to $652000.0; the trailing twelve-month figure through Dec 2025 stood at $652000.0 (up 98.18% YoY), and the FY2025 full-year result was $652000.0, up 98.18% from the prior year.
- Notes Payables for Q4 2025 stood at $652000.0, up from $1000.0 in the prior quarter.
- The five-year high for Notes Payables was $75.4 million in Q3 2023, with the low at $1000.0 in Q2 2022.
- Historically, Notes Payables has averaged $6.8 million across 5 years, with a median of $60000.0 in 2021.
- The largest YoY upside for Notes Payables was 3203300.0% in 2024 against a maximum downside of 99.95% in 2024.
- Oramed Pharmaceuticals' Notes Payables stood at $66000.0 in 2021, then tumbled by 98.48% to $1000.0 in 2022, then soared by 32400.0% to $325000.0 in 2023, then gained by 1.23% to $329000.0 in 2024, then surged by 98.18% to $652000.0 in 2025.
- The last three Notes Payables figures came in at $652000.0 (Q4 2025), $1000.0 (Q3 2025), and $34000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 652,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Dec 31, 2024 | 329,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 32.03 Mn |
| Dec 31, 2023 | 325,000.00 |
| Sep 30, 2023 | 75.36 Mn |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 70,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Nov 30, 2021 | 66,000.00 |
| Aug 31, 2021 | 54,000.00 |
| Aug 31, 2020 | 90,000.00 |